2023 Subject Index to Legislation

Abortion-related regulations: certain provisions and criminal penalties repealed - AB777

Abortion-related regulations: certain provisions and criminal penalties repealed - SB734

Advanced practice RN licensure system created; nurse-midwife license and practice requirements repealed; prescription authority and medical malpractice insurance provisions; hospital emergency services staffing [Sec. 619-625, 791, 1136-1143, 1147, 1329, 1591, 1592, 1734, 1755-1759, 1761, 1768, 1769, 1884, 2125, 2142-2147, 2301, 2305, 2307, 2308, 2310, 2313, 2315, 2316, 2582, 2583, 2585-2589, 2591-2599, 2601, 2602, 2619-2622, 2640, 2642, 2732, 2753, 2779, 2780, 2794, 2796, 2797, 2804, 2805, 2822, 2824, 2839, 2840, 2842, 2845-2853, 2855, 2857, 2858, 2860-2865, 2867-2872, 2874-2878, 2945-2948, 2957, 2958, 2961, 2969, 2977-2979, 2981, 2987-2993, 3028, 3112-3132, 3318, 3324, 9138 (3), 9438 (3)] - AB43

Advanced practice RN licensure system created; nurse-midwife license and practice requirements repealed; prescription authority and medical malpractice insurance provisions - AB154

Advanced practice RN licensure system created; nurse-midwife license and practice requirements repealed; prescription authority and medical malpractice insurance provisions; hospital emergency services staffing [Sec. 619-625, 791, 1136-1143, 1147, 1329, 1591, 1592, 1734, 1755-1759, 1761, 1768, 1769, 1884, 2125, 2142-2147, 2301, 2305, 2307, 2308, 2310, 2313, 2315, 2316, 2582, 2583, 2585-2589, 2591-2599, 2601, 2602, 2619-2622, 2640, 2642, 2732, 2753, 2779, 2780, 2794, 2796, 2797, 2804, 2805, 2822, 2824, 2839, 2840, 2842, 2845-2853, 2855, 2857, 2858, 2860-2865, 2867-2872, 2874-2878, 2945-2948, 2957, 2958, 2961, 2969, 2977-2979, 2981, 2987-2993, 3028, 3112-3132, 3318, 3324, 9138 (3), 9438 (3)] [original bill only] - SB70

Advanced practice RN licensure system created; nurse-midwife license and practice requirements repealed; prescription authority and medical malpractice insurance provisions - SB145

Brand name drug manufacturer discounts used to reduce cost sharing charged to enrollees [Sec. 727, 728, 1177, 2219, 2402, 3058, 3086, 9323 (5)] - AB43

Brand name drug manufacturer discounts used to reduce cost sharing charged to enrollees [Sec. 727, 728, 1177, 2219, 2402, 3058, 3086, 9323 (5)] [original bill only] - SB70

Brand name prescription drug payments made by enrollee applied to health insurance out-of-pocket maximum or cost-sharing requirements - AB103

Brand name prescription drug payments made by enrollee applied to health insurance out-of-pocket maximum or cost-sharing requirements - SB100

Drug Evaluation and Classification Program in DOT: funding provision - AB1188

Drug products prescribed to counteract anaphylaxis: therapeutic interchange by pharmacist allowed - AB849

Drug products prescribed to counteract anaphylaxis: therapeutic interchange by pharmacist allowed - SB783

Duty of pharmacists to dispense any lawfully prescribed drug or device without delay - AB626

Duty of pharmacists to dispense any lawfully prescribed drug or device without delay - SB705

Epinephrine auto-injector: cost sharing under health insurance policies and plans capped - AB1044

Epinephrine auto-injector: cost sharing under health insurance policies and plans capped - SB935

Epinephrine delivery systems: definition, authority to use, and prescribing authority - AB9

Epinephrine delivery systems: definition, authority to use, and prescribing authority [S.Amdt.1: premeasured epinephrine specified] - SB7

Epinephrine for ambulances: DHS to reimburse ambulance service providers, conditions specified [Sec. 2631] - AB43

Epinephrine for ambulances: DHS to reimburse ambulance service providers, conditions specified - AB848

Epinephrine for ambulances: DHS to reimburse ambulance service providers, conditions specified [Sec. 2631] [original bill only] - SB70

Epinephrine for ambulances: DHS to reimburse ambulance service providers, conditions specified - SB782

Federal drug pricing program (340B program): reimbursing certain entities and imposing a fee or other adjustment prohibited; OCI duties [Sec. 3091] - AB43

Federal drug pricing program (340B program): reimbursing certain entities and imposing a fee or other adjustment prohibited; OCI duties [Sec. 3091] [original bill only] - SB70

Health care: cost-sharing for prescription drugs under MA eliminated and cap on insulin; pharmacy benefit managers fiduciary and disclosure requirements; reimbursements for certain 340B program entities; drug repository program changes; value-based diabetes medication pilot project; pharmacist continuing education credits re volunteering at free clinics; prescription drug importation program; pharmacy benefits tool grants; prescription drug purchasing entity study; pharmacy services administrative organization licensing required; pharmaceutical representatives licensure; insulin safety net programs; JRCCP may report - AB748

Health care: cost-sharing for prescription drugs under MA eliminated and cap on insulin; pharmacy benefit managers fiduciary and disclosure requirements; reimbursements for certain 340B program entities; drug repository program changes; value-based diabetes medication pilot project; pharmacist continuing education credits re volunteering at free clinics; prescription drug importation program; pharmacy benefits tool grants; prescription drug purchasing entity study; pharmacy services administrative organization licensing required; pharmaceutical representatives licensure; insulin safety net programs; JRCCP may report - SB719

ID cards required to pick up certain prescribed controlled substances: adding certain ID cards and documents issued by a foreign government - AB445

ID cards required to pick up certain prescribed controlled substances: adding certain ID cards and documents issued by a foreign government - SB441

Insulin cost sharing cap set [Sec. 3096-3098, 9423 (3)] - AB43

Insulin cost sharing cap set [Sec. 3096-3098, 9423 (3)] [original bill only] - SB70

Insulin: cost sharing under health insurance policies and plans capped - AB584

Insulin: cost sharing under health insurance policies and plans capped - SB574

Insulin safety net programs created, reports required [Sec. 3090] - AB43

Insulin safety net programs created, reports required [Sec. 3090] [original bill only] - SB70

MA payment for puberty-blocking drugs or gender reassignment surgery prohibited [S.Sub.Amdt.2: Sec. 308-311] - SB70

Medical aid in dying provisions created; JRCCP may report - AB781

Medical aid in dying provisions created; JRCCP may report - SB739

Medical cannabis program created; Office of Medical Cannabis Regulation created in DHS; grower, producer, and testing laboratory licenses ; patient and caregiver registry; dispensaries, prescription drug monitoring program, child placement and custody, fair employment law, UI, WC, open housing law, sales tax exemption, and criminal penalty provisions; reports from JRCCP, JSCTE, and DOA - AB1040

Medicinal psilocybin treatment on patients with PTSD: pilot program at UW Madison established; trust fund and FDA provisions - AB753

Medicinal psilocybin treatment on patients with PTSD: pilot program at UW Madison established; trust fund and FDA provisions - SB727

Naloxone or other opioid antagonist: court can order criminal defendant to pay law enforcement agency’s costs for administration of - AB1058

Naloxone or other opioid antagonist: court can order criminal defendant to pay law enforcement agency’s costs for administration of - SB974

Opioid antagonist: funding to entities for purchase of [Sec. 802] - AB43

Opioid antagonist: funding to entities for purchase of [Sec. 802] [original bill only] - SB70

Opioid antagonist supply available in public schools and independent charter schools required [Sec. 2121, 2122] - AB43

Opioid antagonist supply available in public schools and independent charter schools required [A.Sub.Amdt.1: further revisions, provisions changed to civil liability exemption for administering an opioid antagonist re elementary and secondary schools] - AB223

Opioid antagonist supply available in public schools and independent charter schools required [Sec. 2121, 2122] [original bill only] - SB70

Opioid antagonist supply available in public schools and independent charter schools required - SB206

Pharmacy benefit managers: revisions to regulations, pharmaceutical product reimbursements, drug formularies, pharmacy networks, audits, fiduciary and disclosure requirements, application of prescription drug payments, discriminatory reimbursement of 340B entities, and retaliation for reporting alleged violations - AB773

Pharmacy benefit managers: revisions to regulations, pharmaceutical product reimbursements, drug formularies, pharmacy networks, audits, fiduciary and disclosure requirements, application of prescription drug payments, discriminatory reimbursement of 340B entities, and retaliation for reporting alleged violations - SB737

Prescription Drug Affordability Review Board created; Office of Prescription Drug Affordability created in OCI, FTE positions - AB747

Prescription Drug Affordability Review Board created; Office of Prescription Drug Affordability created in OCI, FTE positions - SB718

Prescription Drug Affordability Review Board created [Sec. 64, 76, 3042-3045, 9123 (1), 9423 (1)] - AB43

Prescription Drug Affordability Review Board created [Sec. 64, 76, 3042-3045, 9123 (1), 9423 (1)] [original bill only] - SB70

Prescription drug cost reporting by manufacturers: requirements established - AB1134

Prescription drug cost reporting by manufacturers: requirements established - SB1032

Prescription drug importation program established; JCF approval required [Sec. 3040, 9123 (2)] - AB43

Prescription drug importation program established; JCF approval required [Sec. 3040, 9123 (2)] [original bill only] - SB70

Pupils who have asthma: schools required to adopt a management plan which includes standing orders for short-acting bronchodilators; advanced practice nurse prescriber, physician assistant, and physician provisions and civil liability immunity - AB914

Pupils who have asthma: schools required to adopt a management plan which includes standing orders for short-acting bronchodilators; advanced practice nurse prescriber, physician assistant, and physician provisions and civil liability immunity - SB854

Ready-to-use glucagon rescue therapies: prescriptions and standing orders to public, private, and tribal schools from specified medical personnel; administration by school personnel; civil liability immunity - AB450

Ready-to-use glucagon rescue therapies: prescriptions and standing orders to public, private, and tribal schools from specified medical personnel; administration by school personnel; civil liability immunity [S.Amdt.1: changed to "undesignated glucogon," definitions revised] - SB447

SeniorCare participants allowed to purchase 100-day prescription drug supplies; rule revision and DHS to apply for federal Medicaid waiver [Admin.Code DHS 109.31] - AB259

SeniorCare participants allowed to purchase 100-day prescription drug supplies; rule revision and DHS to apply for federal Medicaid waiver [Admin.Code DHS 109.31] - SB263

Serious mental illness treatment: DHS prohibited from imposing utilization management controls for certain prescription drugs under the MA program - AB654

Serious mental illness treatment: DHS prohibited from imposing utilization management controls for certain prescription drugs under the MA program - SB618

State prescription drug purchasing entity study [Sec. 9123 (4)] - AB43

State prescription drug purchasing entity study [Sec. 9123 (4)] [original bill only] - SB70

Step therapy protocol for certain cancer drugs: insurer, pharmacy benefit manager, or utilization review organization prohibited from requiring - AB836

Step therapy protocol for certain cancer drugs: insurer, pharmacy benefit manager, or utilization review organization prohibited from requiring - SB807

Value-based diabetes medication pilot project [Sec. 3039] - AB43

Value-based diabetes medication pilot project [Sec. 3039] [original bill only] - SB70

Value-based purchasing arrangements under MA: DHS may enter into with a drug manufacturer - AB687

Value-based purchasing arrangements under MA: DHS may enter into with a drug manufacturer - SB672

drugs _ criminal acts and law enforcement Drugs — Criminal acts and law enforcement

Demolition of abated former drug dwellings: appropriation for reimbursements to DMA [Sec. 477] - AB43

Demolition of abated former drug dwellings: appropriation for reimbursements to DMA [Sec. 477] [original bill only] - SB70

First-degree reckless homicide re certain controlled substances: felony penalty changes; JRCCP may report - AB68

First-degree reckless homicide re certain controlled substances: felony penalty changes; JRCCP may report - SB101

Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent [Sec. 3334-3336] - AB43

Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent - AB634

Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent [Sec. 3334-3336] [original bill only] - SB70

Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent - SB595

Indoor smoking ban applied to electronic smoking devices and marijuana; “smoking” definition revised - AB1062

Kratom products made from the leaf of the Mitragyna speciosa plant: manufacture, distribution, delivery, and possession regulated - AB393

Kratom products made from the leaf of the Mitragyna speciosa plant: manufacture, distribution, delivery, and possession regulated - SB445

Marijuana legalization: recreational use amount limited; production, processing, and selling permit; medical marijuana registry; drug screening and testing; employment discrimination; excise tax and community reinvestment fund provisions; JRCCP may report; JSCTE appendix report; JLC study [Sec. 267, 268, 419, 523, 537, 598, 1023, 1128, 1156, 1157, 1174, 1180, 1544, 1602, 1730-1732, 1735, 1896, 1898, 1925, 1926, 1942, 2023, 2024, 2043, 2294, 2319, 2320, 2581, 2666, 2786, 3317, 3319-3323, 3325-3333, 3341, 3343-3349, 3355, 3356, 3362-3365, 3374, 9128 (1)] - AB43

Marijuana legalization: recreational use amount limited; production, processing, and selling permit; medical marijuana registry; drug screening and testing; employment discrimination; equity grants; excise tax; law enforcement training program; JRCCP may report; JSCTE appendix report - AB506